LOUIS G LANGE
CIK 1238401 · EVP Cardiovascular Therapeutic · last filed 2026-03-12
LOUIS G LANGE is an EVP Cardiovascular Therapeutic who has filed 72 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing shows the insider sold $1.4M of NAMSW on Mar 12, 2026. Across all open-market trades the lifetime net is −$20.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $852.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$852.1K
6
72
-$20.78M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NAMSW | Director | 10,360 | $19.38 | $200.8K | -$2.09M | 10 | 2026-03-12 |
| BOLD | Director | 0 | $2.47 | $0 | -$9.35M | 19 | 2020-01-15 |
| CymaBay Therapeutics, Inc. (CBAY) Delisted | Director | — | $32.48 | — | $0 | 2 | 2015-06-30 |
| ESPR | Director | 204,803 | $3.18 | $651.3K | $199.0K | 1 | 2013-07-01 |
| GILD | EVP Cardiovascular Therapeutic | — | $134.32 | — | $0 | 2 | 2009-05-08 |
| CV THERAPEUTICS INC (CVTX) Delisted | Chairman & CEO | 490,432 | — | — | -$9.54M | 25 | 2009-04-17 |
Recent Filings
72 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-12 | NAMSW | Sell (S) | −44,619 | -$1.36M | EDGAR |
| 2026-03-11 | NAMS | Notice (144) | −44,619 | -$1.40M | EDGAR |
| 2026-03-10 | NAMSW | Mixed | +16,433 | -$315.8K | EDGAR |
| 2026-03-06 | NAMS | Notice (144) | −28,186 | -$878.8K | EDGAR |
| 2026-01-09 | NAMSW | Grant (A) | +3,400 | $0 | EDGAR |
| 2025-06-03 | NAMSW | Exer (M) | +68 | $0 | EDGAR |
| 2025-05-02 | NAMSW | Exer (M) | +69 | $0 | EDGAR |
| 2025-04-21 | NAMSW | Exer (M) | +69 | $0 | EDGAR |
| 2025-03-28 | NAMSW | Mixed | +3,102 | $0 | EDGAR |
| 2025-01-08 | NAMSW | Grant (A) | +6,960 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.